• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎的严重程度是否影响相关溃疡性结肠炎的临床病程?

Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

机构信息

Liver Transplantation and Hepatobiliary Medicine Unit, Royal Free Hospital, Pond Street, London NW3 2QG, UK.

出版信息

Gut. 2011 Sep;60(9):1224-8. doi: 10.1136/gut.2010.235408. Epub 2011 Mar 14.

DOI:10.1136/gut.2010.235408
PMID:21402617
Abstract

BACKGROUND AND AIMS

Ulcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is usually clinically mild. The aim of the study was to assess whether there is an association between severity of PSC and activity of UC, comparing the course of UC in patients with PSC not needing liver transplantation (LT) and those eventually transplanted.

METHODS

Between 1990 and 2009, 96 consecutive patients with PSC/UC were seen in the authors' institution. Data were evaluated from a database regarding UC activity (median follow-up 144 months). Follow-up was censored at time of LT or last clinical review.

RESULTS

Patients with PSC/UC were divided into two groups: 46 did not need LT (no-LT) and 50 were transplanted (LT). There were no significant differences concerning duration of UC or PSC and extent of UC. The LT group had significantly (p=0.002) more clinically quiescent UC compared with the no-LT group. The LT group had fewer UC flare-ups (p=0.04) and required fewer steroid courses (p=0.025) with shorter duration (p=0.022) and less use of azathioprine (p=0.003). There was an increased need for surgery in the no-LT group (p=0.006). Colon carcinoma and high grade dysplasia were more frequent in the no-LT group (p=0.004). The no-LT group had increased inflammation in the colonic mucosa at histology (p=0.011), but without visual difference at colonoscopy.

CONCLUSIONS

Clinically progressive PSC requiring LT is associated with a milder course of UC (reduced disease activity and less use of steroids, azathioprine and surgery). This is paralleled by less histological activity and reduced incidence of dysplasia and colon carcinoma.

摘要

背景与目的

溃疡性结肠炎(UC)合并原发性硬化性胆管炎(PSC)通常临床症状较轻。本研究旨在评估PSC 严重程度与 UC 活动度之间是否存在关联,比较未行肝移植(LT)和最终行 LT 的 PSC 合并 UC 患者的 UC 病程。

方法

1990 年至 2009 年,作者所在机构共收治 96 例 PSC/UC 连续患者。从数据库中评估 UC 活动度数据(中位随访 144 个月)。LT 或最后临床随访时截尾。

结果

PSC/UC 患者分为两组:46 例未行 LT(无 LT 组)和 50 例行 LT(LT 组)。两组 UC 病程和 PSC 持续时间及 UC 范围无显著差异。与无 LT 组相比,LT 组 UC 更趋于临床缓解(p=0.002)。LT 组 UC 发作次数较少(p=0.04),皮质类固醇疗程较少(p=0.025),疗程较短(p=0.022),且更少使用硫唑嘌呤(p=0.003)。无 LT 组需要手术的患者更多(p=0.006)。无 LT 组结直肠癌和高级别异型增生更为常见(p=0.004)。无 LT 组结肠黏膜组织学炎症更明显(p=0.011),但结肠镜下无明显差异。

结论

需要 LT 的进行性 PSC 与 UC 病情较轻相关(疾病活动度降低,皮质类固醇、硫唑嘌呤和手术应用减少)。这与组织学活性降低、异型增生和结肠癌发生率降低有关。

相似文献

1
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?原发性硬化性胆管炎的严重程度是否影响相关溃疡性结肠炎的临床病程?
Gut. 2011 Sep;60(9):1224-8. doi: 10.1136/gut.2010.235408. Epub 2011 Mar 14.
2
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.进展性原发性硬化性胆管炎需要肝移植与溃疡性结肠炎患者结肠切除术需求减少相关。
Clin Gastroenterol Hepatol. 2012 May;10(5):540-6. doi: 10.1016/j.cgh.2012.01.006. Epub 2012 Jan 13.
3
Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.患有和未患有原发性硬化性胆管炎的溃疡性结肠炎患者的临床病程。
J Gastroenterol Hepatol. 2005 Mar;20(3):366-70. doi: 10.1111/j.1440-1746.2005.03727.x.
4
Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.人类白细胞抗原-DR和-DQ联合错配与原发性硬化性胆管炎肝移植术后溃疡性结肠炎的稳定病程相关。
Liver Transpl. 2007 Apr;13(4):552-7. doi: 10.1002/lt.21077.
5
Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.原发性硬化性胆管炎的持续时间和严重程度与溃疡性结肠炎患者结肠发生肿瘤性变化的风险无关。
Gastrointest Endosc. 2012 May;75(5):1045-1054.e1. doi: 10.1016/j.gie.2012.01.015. Epub 2012 Mar 8.
6
Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎肝移植术后炎症性肠病患者的结直肠癌
Transplantation. 2003 Jun 27;75(12):1983-8. doi: 10.1097/01.TP.0000058744.34965.38.
7
Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.原发性硬化性胆管炎患者溃疡性结肠炎的病理特征:一项病例对照研究。
Am J Surg Pathol. 2009 Jun;33(6):854-62. doi: 10.1097/PAS.0b013e318196d018.
8
Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.肝移植后合并原发性硬化性胆管炎和溃疡性结肠炎患者的溃疡性结肠炎临床病程
Inflamm Bowel Dis. 2017 Jul;23(7):1160-1167. doi: 10.1097/MIB.0000000000001105.
9
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.原发性硬化性胆管炎的溃疡性结肠炎患者患癌症或发育异常的风险。
Am J Gastroenterol. 1999 Jun;94(6):1643-9. doi: 10.1111/j.1572-0241.1999.01156.x.
10
The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis.肝移植对原发性硬化性胆管炎合并溃疡性结肠炎患者结肠炎临床病程的影响。
Aliment Pharmacol Ther. 2012 May;35(9):1054-63. doi: 10.1111/j.1365-2036.2012.05067.x. Epub 2012 Mar 19.

引用本文的文献

1
Long-term impact of scheduled regular endoscopic interventions for patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者定期行内镜介入治疗的长期影响。
Hepatol Commun. 2024 Sep 3;8(9). doi: 10.1097/HC9.0000000000000494. eCollection 2024 Sep 1.
2
Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.孤立性原发性硬化性胆管炎患者肝纤维化进展升高及原发性硬化性胆管炎-炎症性肠病队列中恶性肿瘤风险增加:一项回顾性研究。
Int J Mol Sci. 2023 Oct 21;24(20):15431. doi: 10.3390/ijms242015431.
3
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.
原发性硬化性胆管炎(PSC)伴或不伴炎症性肠病(IBD)的肝移植-欧洲器官移植学会(ESOT)共识声明。
Transpl Int. 2023 Sep 29;36:11729. doi: 10.3389/ti.2023.11729. eCollection 2023.
4
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD):一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.
5
Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis.原发性硬化性胆管炎伴溃疡性结肠炎的发病情况和不良临床事件。
Int J Colorectal Dis. 2023 Jun 23;38(1):175. doi: 10.1007/s00384-023-04464-z.
6
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.结肠炎通过抑制胆汁酸合成改善胆汁淤积性肝病。
Nat Commun. 2023 Jun 6;14(1):3304. doi: 10.1038/s41467-023-38840-8.
7
The microbiota and the gut-liver axis in primary sclerosing cholangitis.原发性硬化性胆管炎中的微生物群与肠-肝轴
Nat Rev Gastroenterol Hepatol. 2023 Mar;20(3):135-154. doi: 10.1038/s41575-022-00690-y. Epub 2022 Nov 9.
8
Liver manifestations and complications in inflammatory bowel disease: A review.炎症性肠病的肝脏表现及并发症:综述
World J Hepatol. 2021 Dec 27;13(12):1956-1967. doi: 10.4254/wjh.v13.i12.1956.
9
Characteristic features of ulcerative colitis with concomitant primary sclerosing cholangitis.溃疡性结肠炎合并原发性硬化性胆管炎的特征
Prz Gastroenterol. 2021;16(3):184-187. doi: 10.5114/pg.2021.108983. Epub 2021 Sep 17.
10
Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease.系统评价与荟萃分析:共病免疫介导的炎症性疾病对克罗恩病疾病定位和行为的影响
Therap Adv Gastroenterol. 2021 Jun 22;14:17562848211004839. doi: 10.1177/17562848211004839. eCollection 2021.